Publications of Phyllis Irene Warkentin - Research Nebraska

Publications

This view shows all the publications associated to this researcher. Select a tab to view the documents within each secion. If you are an authorized user, you can add content by selecting the Edit your profile button above. Access to this tool is managed by a project team at your institution.

88 Publications from Scopus

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

sort by year | cited by

Select All | Save icon

Export

1.
2013

Burak Gumuscu; Elizabeth I. Thompson; Alfred C. Grovas; Terrence L. Zach; Phyllis I. Warkentin; Peter F. Coccia

Successful unrelated cord blood transplantation for homozygous α-thalassemia
Journal of Pediatric Hematology/Oncology 2013;():.

0
2.
2012

D. Gülen; S. Maas; H. Julius; P. Warkentin; H. Britton; I. Younos; J. Senesac; Samuel M. Pirruccello; J.E. Talmadge

Cryopreservation of adenovirus-transfected dendritic cells (DCs) for clinical use
International Immunopharmacology 2012;13(1):61-68.

0
3.
2011

Richard E. Harris; Amanda M. Termuhlen; Lynette M. Smith; James Lynch; Michael M. Henry; Sherrie L. Perkins; Thomas G. Gross; Phyllis Warkentin; Adrianna Vlachos; Lauren Harrison; et al.

Autologous Peripheral Blood Stem Cell Transplantation in Children with Refractory or Relapsed Lymphoma: Results of Children's Oncology Group Study A5962
Biology of Blood and Marrow Transplantation 2011;17(2):249-258.

5
4.
2008

Dumrul Gulen; Fuminori Abe; Sarah Maas; Elizabeth Reed; Kenneth Cowan; Samuel Pirruccello; James Wisecarver; Phyllis Warkentin; Matt Northam; et al.

Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors
International Immunopharmacology 2008;8(13-14):1728-1736.

7
5.
2007

P. Ashford; P. Distler; A. Gee; A. Lankester; S. Larsson; I. Feller; K. Loper; D. Pamphilon; L. Poston; F. Rabe; et al.

Terminology and labeling of cellular products: 1. Standards
Bone Marrow Transplantation 2007;40(11):1075-1083.

3
6.
2007

P. Ashford; P. Distler; A. Gee; A. Lankester; S. Larsson; I. Feller; K. Loper; D. Pamphilon; L. Poston; F. Rabe; et al.

Terminology and labeling of cellular products-2: Implementation plan
Bone Marrow Transplantation 2007;40(11):1085-1090.

2
7.
2007

Paul Ashford; Pat Distler; Adrian Gee; Alan Lankester; Stella Larsson; Irene Feller; Kathy Loper; Derwood Pamphilon; Leigh Poston; Fran Rabe; et al.

Standards for the terminology and labeling of cellular therapy products
Transfusion 2007;47(7):1319-1327.

4
8.
2007

Paul Ashford; Pat Distler; Adrian Gee; Alan Lankester; Stella Larsson; Irene Feller; Kathy Loper; Derwood Pamphilon; Leigh Poston; Fran Rabe; et al.

ISBT 128 implementation plan for cellular therapy products
Transfusion 2007;47(7):1312-1318.

3
9.
2007

Paul Ashford; Pat Distler; Adrian Gee; Alan Lankester; Stella Larsson; Irene Feller; Kathy Loper; Derwood Pamphilon; Leigh Poston; Fran Rabe; et al.

Standards for the terminology and labeling of cellular therapy products
Journal of Clinical Apheresis 2007;22(5):249-257.

2
10.
2007

Paul Ashford; Pat Distler; Adrian Gee; Alan Lankester; Stella Larsson; Irene Feller; Kathy Loper; Derwood Pamphilon; Leigh Poston; Fran Rabe; et al.

ISBT 128 implementation plan for cellular therapy products
Journal of Clinical Apheresis 2007;22(5):258-264.

2
11.
2003

Robert J. Wells; Mary T. Adams; Todd A. Alonzo; Robert J. Arceci; Jonathan Buckley; Allen B. Buxton; Kathryn Dusenbery; Alan Gamis; Margaret Masterson; Terry Vik; et al.

Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951
Journal of Clinical Oncology 2003;21(15):2940-2947.

34
12.
2003

Simon P. Horslen; Timothy C. McCowan; Timothy C. Goertzen; Phyllis I. Warkentin; Hung Bo Cai; Stephen C. Strom; Ira J. Fox

Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder
Pediatrics 2003;111(6 I):1262-1267.

145
13.
2003

Phyllis I. Warkentin

Hematopoietic stem and progenitor cell transplants: Regulation and accreditation
Pediatric Transplantation 2003;7(SUPPL. 3):101-108.

3
14.
2003

Phyllis I. Warkentin

Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT)
Cytotherapy 2003;5(4):299-305.

14
15.
2001

N.L. Kobrinsky; R. Sposto; N.R. Shah; J.R. Anderson; C. DeLaat; M. Morse; P. Warkentin; G.S. Gilchrist; M.D. Cohen; D. Shina; et al.

Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and L-asparaginase, maintenance chemotherapy, and transplantation: Children's cancer group study CCG-5912
Journal of Clinical Oncology 2001;19(9):2390-2396.

42
16.
2001

Ronald J. Rubocki; Jennifer R. Parsa; Michael S. Hershfield; Warren G. Sanger; Samuel J. Pirruccello; Ines Santisteban; Bruce G. Gordon; Sarah E. Strandjord; Phyllis I. Warkentin; et al.

Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency
Blood 2001;97(3):809-811.

12
17.
2001

Manabu Hirai; Drake LaFace; Simon Robinson; Linda Kelsey; Robert Johnson; Shu Fen Wen; Phyllis Warkentin; Kevin Mills; Mei Vaillancourt; Jennifer Chavez; et al.

Ex vivo purging by adenoviral p53 gene therapy does not affect NOD-SCID repopulating activity of human CD34⁺ cells
Cancer Gene Therapy 2001;8(12):936-947.

5
18.
2000

P.I. Warkentin; L. Nick; E.J. Shpall

FAHCT accreditation: Common deficiencies during on-site inspections
Cytotherapy 2000;2(3):213-220.

9
19.
2000

S.S. Joshi; K. Miller; J.D. Jackson; P. Warkentin; A. Kessinger

Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients
Cytotherapy 2000;2(1):15-24.

7
20.
2000

Talmadge; M. Hirai; D. Laface; S.N. Robinson; L. Kelsey; R. Johnson; S. Fen Wen; P.L. Warkentin; K. Mills; M. Vaillancourt; et al.

Nod-scid reconstitution by human cd34+ cells treatead with a replication-deficient, recombinant adenovirl fs vector containing the wild-type p53 gene (rad-p53). J. e
Blood 2000;96(11 PART I):220a.

0
21.
1999

A.G. Ageitos; M.L. Varney; P.J. Bierman; J.M. Vose; P.I. Warkentin; J.E. Talmadge

Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products
Bone Marrow Transplantation 1999;23(1):63-69.

34
22.
1999

S.J. Pirruccello; C.J. Page; M.R. Bishop; B.A. Letheby; P.I. Warkentin; J.D. Jackson; A. Kessinger

Comparison of ISHAGE protocol CD34 cell enumeration with a lineage negative backgating technique
Cytotherapy 1999;1(4):279-286.

3
23.
1998

Ira J. Fox; Jayanta Roy Chowdhury; Stuart S. Kaufman; Timothy C. Goertzen; Namita Roy Chowdhury; Phyllis I. Warkentin; Kenneth Dorko; Bernhard V. Sauter; Stephen C. Strom

Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation
New England Journal of Medicine 1998;338(20):1422-1426.

563
24.
1998

Z.S. Pavletic; S.S. Joshi; S.J. Pirruccello; S.R. Tarantolo; J. Kollath; E.C. Reed; P.J. Bierman; J.M. Vose; P.I. Warkentin; et al.

Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies
Bone Marrow Transplantation 1998;21(1):33-41.

71
25.
1997

B.G. Gordon; P.I. Warkentin; S.E. Strandjord; M. Abromowitch; E. Bayever; J.L. Harper; P.F. Coccia

Allogeneic bone marrow transplantation for children with acute leukemia: Long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation
Bone Marrow Transplantation 1997;20(1):5-10.

15
26.
1997

Michael R. Bishop; Stefano R. Tarantolo; John D. Jackson; James R. Anderson; Kim Schmit-Pokorny; Diane Zacharias; Zivko S. Pavletic; Samuel J. Pirruccello; Julie M. Vose; Philip J. Bierman; et al.

Allogeneic-blood stem-cell collection following mobilization with low- dose granulocyte colony-stimulating factor
Journal of Clinical Oncology 1997;15(4):1601-1607.

23
27.
1997

E.J. Shpall; R.E. Champlin; A.C. Eaves; A.P. Gee; N. Collins; C.F. LeMaistre; R. O'Reilly; S.D. Rowley; K. Sullivan; W.P. Vaughan; et al.

Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket No. 97N-0068)
Journal of Hematotherapy 1997;6(4):287-289.

0
28.
1997

M.R. Bishop; J.D. Jackson; S.R. Tarantolo; B. O'Kane-Murphy; P.L. Iversen; E. Bayever; S.M. Joshi; J.G. Sharp; J.L. Pierson; P.I. Warkentin; et al.

Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome
Journal of Hematotherapy 1997;6(5):441-446.

20
29.
1996

Stephen A. Feig; Matthew M. Ames; Harland N. Sather; Laurel Steinherz; Joel M. Reid; Michael Trigg; Thomas W. Pendergrass; Phyllis Warkentin; Mirjam Gerber; Marcia Leonard; et al.

Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: A report from the Children's Cancer Group
Medical and Pediatric Oncology 1996;27(6):505-514.

23
30.
1996

Charles Peters; Michael Balthazor; Elsa G. Shapiro; Roberta J. King; Craig Kollman; Janet D. Hegland; Jean Henslee-Downey; Michael E. Trigg; Morton J. Cowan; Jean Sanders; et al.

Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome
Blood 1996;87(11):4894-4902.

177
31.
1996

M.R. Bishop; J.D. Jackson; B. O'Kane-Murphy; K. Schmit-Pokorny; J.M. Vose; P.J. Bierman; P.I. Warkentin; J.O. Armitage; L. Garrison; A. Kessinger

Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells
Journal of Clinical Oncology 1996;14(9):2521-2526.

20
32.
1995

G. Phillips; J. Armitage; S. Bearman; J. Bitran; J. Fay; S. Forman; D. Hurd; H. Lazarus; P. Warkentin; et al.

American Society for Blood and Marrow Transplantation guidelines for clinical centers.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1995;1(1):54-55.

1
33.
1995

A. Kessinger; M.R. Bishop; J.D. Jackson; B. O'Kane-Murphy; J.M. Vose; P.J. Bierman; E.C. Reed; P.I. Warkentin; J.O. Armitage; J.G. Sharp

Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies
Experimental Hematology 1995;23(7):609-612.

22
34.
1995

A. Kessinger; M.R. Bishop; J.R. Anderson; J.O. Armitage; P.J. Bierman; E.C. Reed; S. Tarantolo; M.A. Tempero; J.M. Vose; et al.

Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilization
Journal of Hematotherapy 1995;4(2):81-84.

4
35.
1994

Michael R. Bishop; James R. Anderson; John D. Jackson; Philip J. Bierman; Elizabeth C. Reed; Julie M. Vose; James O. Armitage; Phyllis I. Warkentin; Anne Kessinger

High-dose therapy and peripheral blood progenitor cell transplantation: Effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft
Blood 1994;83(2):610-616.

81
36.
1994

M. Damon-Burke; P.I. Warkentin; J.D. Jackson; L.G. Weide

Comparison of sterility profiles from slaughterhouse versus surgically removed pancreata for islet isolation with a new semiclosed method involving the COBE 2991
Transplantation Proceedings 1994;26(2):625-627.

3
37.
1994

M. Damon-Burke; P.I. Warkentin; J.D. Jackson; L.G. Weide

Sterility profile for human pancreatic islet harvests using a new semiclosed method involving the COBE 2991
Transplantation Proceedings 1994;26(2):603-605.

1
38.
1994

L.G. Weide; M. Damon-Burke; P.I. Warkentin

Semiclosed system for human and porcine islet isolation using the COBE 2991 cell processor with the triple-bag processing sets
Transplantation Proceedings 1994;26(2):608-609.

5
39.
1994

L.G. Weide; M. Damon-Burke; P. Warkentin; J. Jackson

Comparison of two microbiological culture techniques used to monitor islet cell isolation contamination
Transplantation Proceedings 1994;26(6):3439-3440.

0
40.
1994

R. Alter; B. O'Kane-Murphy; D. Korth; P. Costas; P.N. Wang; L. Welniak; J.F. Greally; C. Kuszynski; P.I. Warkentin; J.D. Jackson

Characterization of hematopoietic stem cells in human cord blood.
Progress in clinical and biological research 1994;389():393-398.

0
41.
1994

P.I. Warkentin; J.D. Jackson; B. Letheby; A. Kessinger

Effective cryopreservation of cytokine-mobilized autologous peripheral blood stem cells using non-controlled rate freezing.
Progress in clinical and biological research 1994;389():643-647.

3
42.
1994

B. O'Kane-Murphy; J.D. Jackson; C. Kuszynski; P. Costas; P.N. Wang; P.I. Warkentin; A. Kessinger

CD34 analysis in erythropoietin mobilized peripheral blood stem cells.
Progress in clinical and biological research 1994;389():371-376.

0
43.
1994

M.R. Bishop; P.I. Warkentin; J.D. Jackson; E. Bayever; P.L. Iversen; V.I. Whalen; J. Lastovica; K. Haines; A. Kessinger

Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemia.
Progress in clinical and biological research 1994;389():183-187.

8
44.
1994

J.D. Jackson; B. Letheby; B. O'Kane Murphy; P. Costas; P.N. Wang; M.R. Bishop; A. Kessinger; P.I. Warkentin

Kinetics of low and high dose granulocyte/macrophage colony stimulating factor mobilization of peripheral blood stem cells.
Progress in clinical and biological research 1994;389():471-477.

1
45.
1994

B. Jershin; J.D. Jackson; K. Schmidt-Pokorny; P.I. Warkentin

Hematopoietic progenitor cells frozen in ampules are satisfactory reference vials for bulk freezing.
Progress in clinical and biological research 1994;389():657-661.

0
46.
1994

T.G. Gross; F.J. Hoge; J.D. Jackson; P.H. Sammut; P.I. Warkentin

Fatal eosinophilic disease following autologous bone marrow transplantation
Bone Marrow Transplantation 1994;14(2):333-337.

8
47.
1993

P.J. Bierman; P. Warkentin; M.R. Hutchins; L.W. Klassen

Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: Response to antithymocyte globulin
Leukemia and Lymphoma 1993;9(1-2):169-171.

16
48.
1993

B.G. Gordon; D.D. Weisenburger; P.I. Warkentin; J. Anderson; W.G. Sanger; M. Bast; D. Gnarra; J.M. Vose; P.J. Bierman; et al.

Peripheral T-cell lymphoma in childhood and adolescence: A clinicopathologic study of 22 patients
Cancer 1993;71(1):257-263.

21
49.
1993

G.J. Levy; R.G. Strauss; H. Hume; L. Schloz; M.A. Albanese; J. Blazina; A. Werner; C. Sotelo-Avila; C. Barrasso; V. Blanchette; et al.

National survey of neonatal transfusion practices: I. Red blood cell therapy
Pediatrics 1993;91(3):523-529.

51
50.
1993

R.G. Strauss; G.J. Levy; C. Sotelo-Avila; M.A. Albanese; H. Hume; L. Schloz; J. Blazina; A. Werner; C. Barrasso; V. Blanchette; et al.

National survey of neonatal transfusion practices: II. Blood component therapy
Pediatrics 1993;91(3):530-536.

34
51.
1992

B.G. Gordon; P.I. Warkentin; D.D. Weisenburger; J.M. Vose; W.G. Sanger; S.E. Strandjord; J.R. Anderson; J.D. Verdirame; P.J. Bierman; et al.

Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents
Blood 1992;80(11):2938-2942.

13
52.
1992

S.A. Feig; M.D. Krailo; R.E. Harris; E. Baum; J.S. Holcenberg; H. Kaizer; L. Steinherz; T.W. Pendergrass; E.F. Saunders; P.L. Warkentin; et al.

Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: A report from the Childrens Cancer Study Group
Medical and Pediatric Oncology 1992;20(2):124-129.

7
53.
1992

B. Letheby; J. Jackson; J. Greally; P. Warkentin; D. Smith; J. Vose; P. Bierman; A. Kessinger; P. Coccia; J. Armitage

Comparison of two methods of bone marrow processing for autologous bone marrow transplantation.
Progress in clinical and biological research 1992;377():345-351.

1
54.
1991

B.G. Gordon; K.L. Saving; J.A. McCallister; P.I. Warkentin; J.R.W.M. McConnell Roberts; P.F. Coccia; W.D. Haire

Cerebral infarction associated with protein C deficiency following allogeneic bone marrow transplantation
Bone Marrow Transplantation 1991;8(4):323-325.

15
55.
1991

B.G. Gordon; S.E. Strandjord; P.I. Warkentin; J. Kadushin; P.F. Coccia

Successful treatment of severe aplastic anemia by bone marrow transplantation from HLA nonidentical family members: Preliminary results utilizing cyclophosphamide and 600 cGY fractionated total body irradiation
American Journal of Pediatric Hematology/Oncology 1991;13(1):29-33.

1
56.
1991

W.P. Vaughan; J.D. Dennison; E.C. Reed; L. Klassen; T.R. McGuire; W.G. Sanger; P.P. Kumar; P.I. Warkentin; B.G. Gordon; P.J. Bierman; et al.

Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapy
Bone Marrow Transplantation 1991;8(6):489-495.

25
57.
1989

J. Stein; P.A. Zimmerman; M. Kochera; S. Strandjord; W. Golden; M. Simon; P. Warkentin; B.R. Blazar; P. Coccia; N. Lang-Unnasch

Origin of leukemic relapse after bone marrow transplantation: Comparison of cytogenetic and molecular analyses
Blood 1989;73(7):2033-2040.

11
58.
1989

A. Kessinger; D.M. Smith; S.E. Strandjord; J.D. Landmark; D.C. Dooley; P. Law; P.F. Coccia; P.I. Warkentin; D.D. Weisenburger; J.O. Armitage

Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia
Bone Marrow Transplantation 1989;4(6):643-646.

91
59.
1988

J.E. Baley; E.K. Stork; P.I. Warkentin; S.B. Shurin

Granulocyte transfusions.
Pediatrics 1988;81(6):915-.

0
60.
1988

J.E. Baley; E.K. Stork; P.I. Warkentin; S.B. Shurin

Neonatal neutropenia. Clinical manifestations, cause, and outcome
American Journal of Diseases of Children 1988;142(11):1161-1166.

39
61.
1988

J. Stein; S. Strandjord; U. Saarinen; P. Warkentin; S. Gerson; H. Lazarus; D. Von Hoff; P. Coccia; N.K. Cheung

In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: a pilot study.
Progress in clinical and biological research 1988;271():237-248.

2
62.
1988

P.F. Coccia; S.E. Strandjord; P.I. Warkentin; N.-K.V. Cheung; E.M. Gordon; L.J. Novak; D.C. Shina; R.H. Herzig

High-dose cytosine arabinoside and fractionated total-body irradiation: An improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission
Blood 1988;71(4):888-893.

37
63.
1987

P.I. Warkentin

Plateletpheresis: an invaluable blood resource.
Cleveland Clinic journal of medicine 1987;54(5):381-383.

0
64.
1987

R.J. Berkowitz; S. Strandjord; P. Jones; C. Hughes; J. Barsetti; E.M. Gordon; N.K. Cheung; P. Warkentin; P.F. Coccia

Stomatologic complications of bone marrow transplantation in a pediatric population.
Pediatric dentistry 1987;9(2):105-110.

23
65.
1987

J.E. Baley; E.K. Stork; P.I. Warkentin; S.B. Shurin

Buffy coat transfusions in neutropenic neonates with presumed sepsis: A prospective, randomized trial
Pediatrics 1987;80(5):712-720.

13
66.
1987

U.M. Saarinen; S.E. Strandjord; P.I. Warkentin; N.-K.V. Cheung; H.M. Lazarus; P.F. Coccia

Differentiation of presumed sepsis from acute graft-versus-host disease by C-reactive protein and serum total IgE in bone marrow transplant recipients
Transplantation 1987;44(4):540-546.

7
67.
1986

P.I. Warkentin; M.S. Dixon Jr.; I. Schafer; S.E. Strandjord; P.F. Coccia

Bone marrow transplantation in Hunter syndrome: A preliminary report
Birth Defects: Original Article Series 1986;22(1):31-39.

9
68.
1986

G.S. Giebink; P.I. Warkentin; N.K.C. Ramsay; J.H. Kersey

Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine
Journal of Infectious Diseases 1986;154(4):590-596.

33
69.
1985

R.H. Herzig; P.F. Coccia; H.M. Lazarus; S.E. Strandjord; J. Graham-Pole; N.-K. Cheung; E.M. Gordon; S. Gross; T.R. Spitzer; P.I. Warkentin; et al.

Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation
Seminars in Oncology 1985;12(2 SUPPL. 3):184-186.

9
70.
1985

N.K. Cheung; U. Saarinen; J. Neely; F. Miraldi; S. Strandjord; P. Warkentin; P. Coccia

Development of neuroblastoma monoclonal antibodies for potential utilization in diagnosis and therapy.
Progress in clinical and biological research 1985;175():501-505.

0
71.
1985

P.I. Warkentin; J.M. Hilden; J.H. Kersey; N.K. Ramsay; J. McCullough

Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch
Vox Sanguinis 1985;48(2):89-104.

32
72.
1985

R.J. Berkowitz; C. Hughes; M. Rudnick; E.M. Gordon; S. Strandjord; N.K. Cheung; P. Warkentin; P.F. Coccia

Oropharyngeal candida prophylaxis in pediatric bone marrow transplant patients
American Journal of Pediatric Hematology/Oncology 1985;7(1):82-86.

6
73.
1985

K. McClain; P. Warkentin; N. Kay

Spontaneous remission of Burkitt's lymphoma associated with herpes zoster infection
American Journal of Pediatric Hematology/Oncology 1985;7(1):9-14.

6
74.
1984

H.M. Lazarus; P.F. Coccia; R.H. Herzig; J. Graham-Pole; S. Gross; S. Strandjord; E. Gordon; N.K. Cheung; P.I. Warkentin; T.R. Spitzer

Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients
Blood 1984;64(1):215-220.

17
75.
1984

J. McCullough; L.C. Lasky; P.I. Warkentin

Role of the blood bank in bone marrow transplantation.
Progress in clinical and biological research 1984;149():379-412.

1
76.
1984

P.I. Warkentin

More on calculations for exchange transfusion.
Transfusion 1984;24(1):86-.

0
77.
1983

P.I. Warkentin

Transfusion of patients undergoing bone marrow transplantation
Human Pathology 1983;14(3):261-266.

3
78.
1983

P.I. Warkentin; D. Yomtovian; R. Hurd; R. Brunning; J. Swanson; J.H. Kersey; J. McCullough

Severe delayed hemolytic transfusion reaction complicating an ABO-incompatible bone marrow transplantation
Vox Sanguinis 1983;45(1):40-47.

11
79.
1983

L.C. Lasky; P.I. Warkentin; J.H. Kersey; N.K. Ramsay; P.B. McGlave; J. McCullough

Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation
Transfusion 1983;23(4):277-285.

33
80.
1982

A.H. Filipovich; P.B. McGlave; N.K.C. Ramsay; G. Goldstein; P.I. Warkentin; J.H. Kesey

Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation
Lancet 1982;1(8284):1266-1269.

24
81.
1981

Phyllis I. Warkentin; Mary E. Clay; John H. Kersey; Norma K.C. Ramsay; Jeffrey McCullough

Successful engraftment of NA1 positive bone marrow in a patient with the neutrophil antibody, anti-NA1
Human Immunology 1981;2(2):173-184.

3
82.
1980

J.R. Priest; L.L. Robison; R.W. McKenna; L.L. Lindquist; P.I. Warkentin; T.W. LeBien; W.G. Woods; J.H. Kersey; P.F. Coccia; M.E. Nesbit Jr.

Philadelphia chromosome positive childhood acute lymphoblastic leukemia
Blood 1980;56(1):15-22.

10
83.
1980

P.F. Coccia; W. Krivit; J. Cervenka; C. Clawson; J.H. Kersey; T.H. Kim; M.E. Nesbit; N.K. Ramsay; P.I. Warkentin; S.L. Teitelbaum; et al.

Successful bone-marrow transplantation for infantile malignant osteopetrosis
New England Journal of Medicine 1980;302(13):701-708.

119
84.
1980

J.H. Kersey; T. Kim; S. Levitt; W. Krivit; M.E. Nesbit; P. Coccia; P. Warkentin; M. O'Leary; N.K. Ramsay

Combined immunosuppression using cyclophosphamide plus total lymphoid irradiation in preparation for allogeneic marrow transplantation in humans.
Hamatologie und Bluttransfusion 1980;25():333-338.

0
85.
1980

P.I. Warkentin; N.K.C. Ramsay; W. Krivit

Immunosuppressive therapy for severe aplastic anemia
American Journal of Pediatric Hematology/Oncology 1980;2(4):327-339.

0
86.
1979

P. Warkentin; D. Hasegawa; M. Nesbit

High dose methotrexate (MTX) hepatotoxicity: Significance of frequency of administration
Proceedings of the American Association for Cancer Research 1979;Vol. 20():393-.

1
87.
1978

J.R. Fenyk Jr.; P.I. Warkentin; C.M. Smith; W. Krivit; R.W. Goltz; J.E. Neely; M.E. Nesbit; N.K. Ramsay; P.F. Coccia; J.H. Kersey

Sclerodermatous graft-versus-host disease limited to an area of measles exanthem
Lancet 1978;1(8062):472-473.

11
88.
1978

P. Warkentin; P. Coccia; N. Ramsay

Acute hepatocellular injury after high dose methotrexate (MTX) infusions
Proceedings of the American Association for Cancer Research 1978;Vol. 19():No. C-121.

1

Phyllis Irene Warkentin University of Nebraska Medical Center, Pathology & Microbiology

Phyllis Irene Warkentin

Publications

88 Publications from Scopus

Phyllis Irene Warkentin
University of Nebraska Medical Center, Pathology & Microbiology